Sei Investments Co. Has $5.14 Million Stock Holdings in Azenta, Inc. $AZTA

Sei Investments Co. raised its position in shares of Azenta, Inc. (NASDAQ:AZTA) by 32.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 243,389 shares of the company’s stock after purchasing an additional 59,752 shares during the period. Sei Investments Co.’s holdings in Azenta were worth $5,143,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of the business. Assetmark Inc. increased its stake in shares of Azenta by 54.1% in the 4th quarter. Assetmark Inc. now owns 832 shares of the company’s stock valued at $28,000 after purchasing an additional 292 shares during the last quarter. Osaic Holdings Inc. boosted its stake in Azenta by 44.9% in the second quarter. Osaic Holdings Inc. now owns 1,242 shares of the company’s stock valued at $39,000 after buying an additional 385 shares in the last quarter. CWM LLC grew its position in Azenta by 27.3% in the fourth quarter. CWM LLC now owns 1,822 shares of the company’s stock valued at $61,000 after acquiring an additional 391 shares during the last quarter. Empowered Funds LLC raised its stake in Azenta by 10.5% during the first quarter. Empowered Funds LLC now owns 6,482 shares of the company’s stock worth $225,000 after acquiring an additional 618 shares in the last quarter. Finally, Neuberger Berman Group LLC lifted its holdings in shares of Azenta by 8.9% in the fourth quarter. Neuberger Berman Group LLC now owns 8,379 shares of the company’s stock worth $279,000 after acquiring an additional 684 shares during the last quarter. Institutional investors and hedge funds own 99.08% of the company’s stock.

Azenta Price Performance

Azenta stock opened at $30.13 on Wednesday. The firm has a market cap of $1.39 billion, a P/E ratio of -7.61 and a beta of 1.37. The stock’s 50 day moving average is $25.07 and its 200 day moving average is $25.60. Azenta, Inc. has a one year low of $15.93 and a one year high of $41.73.

Azenta (NASDAQ:AZTA) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.11 by $0.05. Azenta had a negative net margin of 30.49% and a positive return on equity of 1.23%. The firm had revenue of $161.18 million during the quarter, compared to analyst estimates of $149.31 million.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the stock. Needham & Company LLC lowered their price objective on shares of Azenta from $44.00 to $33.00 and set a “buy” rating for the company in a research report on Wednesday, May 6th. Weiss Ratings upgraded shares of Azenta from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, July 15th. Four equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $40.40.

About Azenta

Azenta, Inc (NASDAQ: AZTA) is a life sciences technology company specializing in sample management, cryogenic storage and genomic services for research and clinical applications. Formerly the Life Sciences division of Brooks Automation, Azenta provides integrated solutions that enable customers to store, track and analyze biological samples with high levels of automation, data integrity and efficiency. Its offerings span automated storage systems, biorepository management software and end?to?end sample tracking workflows.

In addition to hardware and informatics platforms for sample storage, Azenta’s Genomics business delivers next?generation sequencing (NGS), DNA synthesis, and molecular biology services.